Report
Martial Descoutures

Un potentiel masqué par des débuts timides - ACHAT - OC 7€ (vs 9€)

Après la conférence téléphonique d’hier sur le potentiel des HIFU dans le cancer du sein et après révisions de nos estimations, nous ajustons à 7€ (vs 9€) notre OC. Nous actualisons nos estimations de besoin de financement (20m€ vs 10m€) ce qui se répercute négativement sur notre valorisation. Malgré des débuts timorés sur ses marchés cibles, le groupe a posé les fondations inspirant confiance sur l’évolution commerciale à MT. Alors que l’horizon s’éclaircit sur ses marchés historiques, la société étudie de nouvelles indications (maladie de Basedow ou cancer du sein en combinaison) qui, à ce stade, ne sont pas valorisées dans notre OC. Nous maintenons notre recommandation ACHAT.
Underlying
Theraclion SA

Theraclion SA. Theraclion is a France-based company, which develops High Intensity Focused Ultrasound (HiFu) machines. The Company is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The Company provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.

Provider
Invest Securities
Invest Securities

Since 2006, Invest Securities has become one of the leading players in investment services for funds and managers, to whom we offer a global and personalised service. Our track record differentiates us and proves our leadership in numerous promising sectors like property and growth companies.

Consisting of 13 different profiles (pharmacist, engineer, financier, etc), the DNA of our financial analysis office is value added and sector expertise. Through daily monitoring and detailed analyses of companies and sectors, we seek to provide a differentiating vision of our 120 stocks followed. Our ideas are circulated every day to nearly 1,000 professionals.

Analysts
Martial Descoutures

Other Reports on these Companies
Other Reports from Invest Securities
Jamila El Bougrini ... (+2)
  • Jamila El Bougrini
  • Thibaut Voglimacci-Stephanopoli
Jamila El Bougrini ... (+2)
  • Jamila El Bougrini
  • Thibaut Voglimacci-Stephanopoli
Jamila El Bougrini ... (+2)
  • Jamila El Bougrini
  • Thibaut Voglimacci-Stephanopoli

ResearchPool Subscriptions

Get the most out of your insights

Get in touch